About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Alzheimer's Research and Therapy
›
Top Articles
Alzheimer's Research and Therapy
Psychiatry
,
Neurology
,
Biology
,
Neuroscience
,
Neuropsychiatry
,
Clinical Neurology
,
Cognitive Neuroscience
9
(top 1%)
Impact Factor
9.6
(top 1%)
extended IF
84
(top 4%)
H-Index
1.5K
authors
1.2K
papers
33.1K
citations
2.8K
citing journals
24K
citing authors
Most Cited Articles of Alzheimer's Research and Therapy
Title
Year
Citations
Alzheimer's disease drug-development pipeline: few candidates, frequent failures
2014
1K
Recent global trends in the prevalence and incidence of dementia, and survival with dementia
2016
392
Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study
2012
311
Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease
2011
307
Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review
2015
282
BACE1 inhibitor drugs in clinical trials for Alzheimer's disease
2014
279
Dementia: a global health priority - highlights from an ADI and World Health Organization report
2012
267
Plasma tau levels in Alzheimer's disease
2013
262
Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains
2015
243
A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease
2017
243
Drug development in Alzheimer's disease: the path to 2025
2016
234
Alzheimer's disease prevention: from risk factors to early intervention
2017
218
Monoamine oxidase B inhibitor, selegiline, reduces F-THK5351 uptake in the human brain
2017
213
Alpha-synuclein biology in Lewy body diseases
2014
203
Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome
2013
202
On the path to 2025: understanding the Alzheimer's disease continuum
2017
197
Immediate and long-term consequences of COVID-19 infections for the development of neurological disease
2020
196
Clinical subtypes of chronic traumatic encephalopathy: literature review and proposed research diagnostic criteria for traumatic encephalopathy syndrome
2014
185
Truncated and modified amyloid-beta species
2014
180
Prevalence of mixed pathologies in the aging brain
2014
158
The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer's disease
2018
156
Role of neuroinflammation in neurodegeneration: new insights
2017
151
Chronic traumatic encephalopathy: a spectrum of neuropathological changes following repetitive brain trauma in athletes and military personnel
2014
151
Amyloid β-protein oligomers and Alzheimer's disease
2013
150
Bapineuzumab for mild to moderate Alzheimer's disease in two global, randomized, phase 3 trials
2016
148
previous
2011
2012
2013
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.